Applications and limitations of estimation of infarct size from serial changes in plasma creatine phosphokinase activity.
D000208:Acute Disease; D000818:Animals; D002470:Cell Survival; D003402:Creatine Kinase / Q000097:blood* / Q000378:metabolism; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008775:Methylprednisolone / Q000494:pharmacology / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy / Q000201:enzymology*; D009206:Myocardium / Q000201:enzymology; D014294:Trimethaphan / Q000494:pharmacology / Q000627:therapeutic use
D014294:Trimethaphan; D003402:Creatine Kinase; D008775:Methylprednisolone